Illuminating your path to
better health

Ellume delivers innovative diagnostic healthcare solutions enabling people to take increased control of their health and wellbeing.

Influenza (Flu) is a common, serious viral infection.

Influenza infects 5-15% of the world's population annually, with 3-5 million severe cases and 250,000 to 500,000 deaths (WHO).

5 reasons why you need to know if you have flu

Flu is treatable within 2 days (48 hours) of infection with medicines like Tamiflu and Relenza. Beyond 2 days these medicines are of little or no benefit.
If you have flu, you should be extra careful to protect people around you from infection (you’re infectious).
Knowing you have flu has been shown to reduce unnecessary treatments (like antibiotics) and expensive tests (such as xrays and blood tests).
If you get sicker and need to see a doctor or go to hospital, it is important for them to know you have flu – they can look after you (and patients around you) better.
If you don’t have flu, it is important to consider other illnesses which can make you feel like you have flu. Sometimes these can be serious.

It really is “Better to Know”

Ellume delivers global healthcare solutions that enable people to live healthier, happier and more fulfilling lives.

At Ellume our mission is to improve the accessibility, accuracy and efficiency of global healthcare. Through the creation of simple, elegant diagnostic tools we empower people to take increased control of their health and wellbeing.

Innovation at Ellume takes cutting edge diagnostic technology out of the laboratory and makes it work for everyone.

At the clinic, at home, at work – anywhere. Simple, safe and ultra-sensitive.

This is made possible by our pioneering detection technology which puts nanotechnology in the palm of your hand. We call it the Ellume Sensing Platform (ESP) and it is the next generation of immunoassay technology. Learn more…

But ultra-sensitive is of little value unless it is also ultra-usable. So all our innovations are driven by Humanised Design - simple enough for anyone to use, even if they don’t feel at their best.

Ellume has pioneered a
world first in

The Respirio Flu Test will be the world’s first non-invasive, ultra-simple test for the detection of Influenza in the clinic and in the home.
It will be a single use device that uses our proprietary ‘Ellume Sensing Platform’ (ESP), making it sensitive yet affordable. If made early, a flu diagnosis is the first step towards appropriate treatment and better health outcomes. The Respirio Flu Test is undergoing clinical trials and will be available as soon as regulatory authorities have approved its use.

Why testing for Flu is important?  Click here

At Ellume, we focus our energies on conditions that people are affected by everyday.

Currently our team is in the process of applying the ‘Ellume Sensing Platform’ [ESP] to develop world first diagnostic tools for :

•  Pregnancy / Fertility
  Chlamydia
  HIV

The Ellume Sensing Platform (ESP) combines nanotechnology and world-first opto-electronics to create a sensitive and affordable detection solution.

It’s a mini-lab, in your hand, for just a few bucks. And it can change your healthcare world.

Even better, it does the analysing for you, no interpretation, no guessing. 

The ESP is the heart of our innovative products and allows us to create great diagnostic solutions for a range of common, important illnesses. It puts people in charge of their health, right where they should be.

At Ellume we believe our products will change lives for the better, cut costs to healthcare systems and deliver substantial returns to our partners and investors.

If you would like to join us in taking game-changing products to the market, please contact us

Contact Us.
  
Name
Email
Phone
Message